PRELIMINARY REPORT ON MELLARIL IN EPILEPSY
Abstract
1. Mellaril is a smooth acting, efficient therapeutic agent in the treatment of the psychotic patient.
2. Nausea is not masked.
3. Side effects in this study have been negligible.
4. Mellaril proceeds to aid psychotics with their behavioral problems over and beyond what thorazine is able to do.
5. Fewer accidents reported during the 6 month period.
6. Relatives visit chronic epileptics more often and receive greater pleasure from visiting, since all patients have been maintained, improved, or markedly improved.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
